Metabolic perturbations in fibrosis disease
- PMID: 34461262
- DOI: 10.1016/j.biocel.2021.106073
Metabolic perturbations in fibrosis disease
Erratum in
-
Corrigendum to "Metabolic perturbations in fibrosis disease" [Int. J. Biochem. Cell Biol. 139 (2021) 106073].Int J Biochem Cell Biol. 2021 Dec;141:106109. doi: 10.1016/j.biocel.2021.106109. Epub 2021 Oct 30. Int J Biochem Cell Biol. 2021. PMID: 34756815 No abstract available.
Abstract
Metabolic changes occur in all forms of disease but their impact on fibrosis is a relatively recent area of interest. This review provides an overview of the major metabolic pathways, glycolysis, amino acid metabolism and lipid metabolism, and highlights how they influence fibrosis at a cellular and tissue level, drawing on key discoveries in dermal, renal, pulmonary and hepatic fibrosis. The emerging influence of adipose tissue-derived cytokines is discussed and brings a link between fibrosis and systemic metabolism. To close, the concept of targeting metabolism for fibrotic therapy is reviewed, drawing on lessons from the more established field of cancer metabolism, with an emphasis on important considerations for clinical translation.
Keywords: Adipokines; Fibroblasts; Fibrosis; Metabolism; Therapy.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
